T-cell masthead image

A lyophilized formulation of RiVax, a recombinant ricin subunit vaccine, retains immunogenicity

A lyophilized formulation of RiVax, a recombinant ricin subunit vaccine, retains immunogenicity

Smallshaw, J.E. and E.S. Vitetta, A lyophilized formulation of RiVax, a recombinant ricin subunit vaccine, retains immunogenicity. Vaccine, 2010. 28(12): p. 2428-35.

Learn More